nurse and patient

Pelvital Announces Landmark Study Demonstrating Efficacy of Flyte® Device in Treating Stress Urinary Incontinence

Share

Pelvital, the women’s health MedTech company on a mission to transform the standard of care for urinary incontinence, announced today the publication of its landmark paper “Randomized trial of mechanotherapy for the treatment of stress urinary incontinence in women” in the peer-reviewed journal Therapeutic Advances in Urology. The paper presents evidence of the efficacy of Pelvital’s novel, FDA-cleared device, Flyte, for the treatment of stress urinary incontinence (SUI) and weakened pelvic floor muscles, with results comparable to surgical intervention. Read more.

Source: PRNewsire, February 21, 2024

Posted in News and tagged , , , , , .